RO.CH

332.4

+0.42%↑

NOVN.CH

123.18

+0.31%↑

LONN.CH

513.6

0%↓

SDZ.CH

63.8

-0.09%↓

STMN.CH

83.56

+0.14%↑

RO.CH

332.4

+0.42%↑

NOVN.CH

123.18

+0.31%↑

LONN.CH

513.6

0%↓

SDZ.CH

63.8

-0.09%↓

STMN.CH

83.56

+0.14%↑

RO.CH

332.4

+0.42%↑

NOVN.CH

123.18

+0.31%↑

LONN.CH

513.6

0%↓

SDZ.CH

63.8

-0.09%↓

STMN.CH

83.56

+0.14%↑

RO.CH

332.4

+0.42%↑

NOVN.CH

123.18

+0.31%↑

LONN.CH

513.6

0%↓

SDZ.CH

63.8

-0.09%↓

STMN.CH

83.56

+0.14%↑

RO.CH

332.4

+0.42%↑

NOVN.CH

123.18

+0.31%↑

LONN.CH

513.6

0%↓

SDZ.CH

63.8

-0.09%↓

STMN.CH

83.56

+0.14%↑

Kodu・Aktsiate loetelu・Bachem Holding AG

Bachem Holding AG

Suletud

SektorTervishoid

66.05 -1.34

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

66.35

Põhinäitajad
By Trading Economics
Sissetulek	49M 99M
Müük	69M 382M
P/E Sektori keskmine	31.97 56.063
Dividenditootlus	1.42
Kasumimarginaal	25.83
Töötajad	2,130
EBITDA	35M 107M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+33.23% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	1.42% 2.45%

Turustatistika
By TradingEconomics
Turukapital	672M 4.7B
Eelmine avamishind	67.39
Eelmine sulgemishind	66.05

Uudiste sentiment

By Acuity

43%

57%

153 / 349 Pingereas Healthcare

Bachem Holding AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. apr 2026, 23:17 UTC

Tulu

Samsung Forecasts Record First-Quarter Operating Profit

6. apr 2026, 23:00 UTC

Kuumad aktsiad

Stocks to Watch: Health Insurers, Mawson, Owlet

6. apr 2026, 22:13 UTC

Suurimad hinnamuutused turgudel

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6. apr 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6. apr 2026, 17:09 UTC

Suurimad hinnamuutused turgudel

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6. apr 2026, 16:56 UTC

Uudisväärsed sündmused

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6. apr 2026, 14:47 UTC

Suurimad hinnamuutused turgudel

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7. apr 2026, 00:00 UTC

Uudisväärsed sündmused

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6. apr 2026, 23:58 UTC

Market Talk

Uudisväärsed sündmused

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6. apr 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6. apr 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6. apr 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6. apr 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6. apr 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6. apr 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6. apr 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6. apr 2026, 18:36 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 17:59 UTC

Market Talk

Uudisväärsed sündmused

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6. apr 2026, 17:13 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6. apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. apr 2026, 14:59 UTC

Tulu

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Võrdlus sarnastega

Hinnamuutus

Bachem Holding AG Prognoos

Hinnasiht

By TipRanks

33.23% tõus

12 kuu keskmine prognoos

Keskmine 89 CHF 33.23%

Kõrge 110 CHF

Madal 80 CHF

Põhineb 4 Wall Streeti analüütiku instrumendi Bachem Holding AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Bachem Holding AG aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

153 / 349 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.